Effects of Diacutaneous Fibrolysis Over Neuromuscular Response

Effects of Diacutaneous Fibrolysis Over the Gastrocnemious Neuromuscular Response

The study consists in evaluating the neuromuscular response of the gastrocnemious muscles before and after a diacutaneous fibrolysis over the gastrocnemious muscles.

Study Overview

• Status: Unknown
• Conditions: Myofascial Pain Syndrome; Contraction
• Intervention / Treatment: Other: Diacutaneous fibrolysis

• Study Type: Interventional
• Enrollment (Actual): 30
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Spain
  • Barcelona
    • Sant Cugat del Vallès, Barcelona, Spain, 08017
      • Albert Pérez-Bellmunt

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years to 40 years (Adult)
• Accepts Healthy Volunteers: Yes
• Genders Eligible for Study: All

Description

Exclusion Criteria:

• Muscle injury in the last two months
• To not understand the study orders
• Suffer a musculoskeletal disorder that doesn't allow the subject to do the study protocol

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: Single

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
No Intervention: Control
Experimental: Diacutaneous fibrolysis	Other: Diacutaneous fibrolysis; Diacutaneous fibrolysis over the gastrocnemious muscles

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Delay time change	Time between an electric impulse and 10% of the contraction of the muscle that is being excited with an electric impulse, using an electromyography test (miliseconds).	4 minutes before the intervention, 5 minutes after the intervention and 30 minutes later
Contraction time change	Time between 10% and 90% of the contraction of the muscle that is being excited with an electric impulse, using an electromyography test (miliseconds).	4 minutes before the intervention, 5 minutes after the intervention and 30 minutes later
Sustain time change	time between 50% of the contraction and 50% of the relaxation of the muscle after being impulsed with an electric impulse, using an electromyography test (miliseconds).	4 minutes before the intervention, 5 minutes after the intervention and 30 minutes later
Relaxation time change	time between 90% and 50% of the relaxation of the muscle after being impulsed with an electric impulse, using an electromyography test (miliseconds).	4 minutes before the intervention, 5 minutes after the intervention and 30 minutes later
Maximal displacement change	Maximal displacement of the muscle after being excited with an electric impulse, using an electromyography test (miliseconds).	4 minutes before the intervention, 5 minutes after the intervention and 30 minutes later
Stiffness change	Resistance to an external force that deforms its initial shape, using a "Myoton" (Newtons/metre).	2 minutes before the intervention, 7 minutes after the intervention and 30 minutes later
Elasticity change	Capacity to recover its initial shape after the removal of the external force that lead to its deformation, using a "Myoton" (logarithmic decrement of a tissue's natural oscillation).	2 minutes before the intervention, 7 minutes after the intervention and 30 minutes later
Relaxation change	Time for a muscle to recover its shape from deformation after the removal of an external force, using a "Myoton" (miliseconds).	2 minutes before the intervention, 7 minutes after the intervention and 30 minutes later

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Gastrocnemious strength change	Isometric strength of the gastrocnemious muscles using a handheld dynamometer "microFET 2" (newtons).	8 minutes before the intervention, 1 minute after the intervention and 30 minutes later

Collaborators and Investigators

• Sponsor: Universitat Internacional de Catalunya

Study record dates

Study Major Dates

• Study Start (Actual): February 5, 2019
• Primary Completion (Actual): February 5, 2019
• Study Completion (Anticipated): June 5, 2019

Study Registration Dates

• First Submitted: May 20, 2019
• First Submitted That Met QC Criteria: May 23, 2019
• First Posted (Actual): May 28, 2019

Study Record Updates

• Last Update Posted (Actual): May 28, 2019
• Last Update Submitted That Met QC Criteria: May 23, 2019
• Last Verified: February 1, 2019

More Information

Terms related to this study

• Keywords: Neuromuscular response; diacutaneous fibrolysis
• Additional Relevant MeSH Terms: Nervous System Diseases; Musculoskeletal Diseases; Rheumatic Diseases; Muscular Diseases; Neuromuscular Diseases; Fibromyalgia; Myofascial Pain Syndromes
• Other Study ID Numbers: Protocol 5

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No